| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 152.613.543 $ | 95,10 | 8.101.705 | |||||||
| REVOLUTION MEDICINES, INC. | REVOLUTION MEDICINES INC | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 10.999.959 $ | 6,85 | 76.325 | |
| MODERNA, INC. | MODERNA INC | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 10.081.120 $ | 6,28 | 219.441 | |
| IPSEN SA | IPSEN SA | EC | FR0010259150 | Long | Modellwert (Stufe 2) | 8.407.956 $ | 5,24 | 42.810 | |
| Bayer Aktiengesellschaft | BAYER AG | EC | DE000BAY0017 | Long | Modellwert (Stufe 2) | 7.025.574 $ | 4,38 | 156.689 | |
| Takeda Pharmaceutical Company Limited | TAKEDA PHARMACEUTICAL CO LTD | EC | JP3463000004 | Long | Modellwert (Stufe 2) | 6.770.138 $ | 4,22 | 202.500 | |
| MERCK & CO., INC. | MERCK CO INC | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 6.655.176 $ | 4,15 | 60.956 | |
| GSK PLC | GSK PLC | EC | GB00BN7SWP63 | Long | Modellwert (Stufe 2) | 6.617.211 $ | 4,12 | 252.397 | |
| Roche Holding AG | ROCHE HOLDING AG | EC | CH1499059983 | Long | Börsenkurs (Stufe 1) | 6.407.527 $ | 3,99 | 15.724 | |
| EXELIXIS, INC. | EXELIXIS INC | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 6.092.220 $ | 3,80 | 137.027 | |
| Twist Bioscience Corp | TWIST BIOSCIENCE CORP | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 6.075.059 $ | 3,79 | 103.936 | |
| REGENERON PHARMACEUTICALS, INC. | REGENERON PHARMACEUTICALS INC | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 5.983.142 $ | 3,73 | 8.462 | |
| SANOFI SA | SANOFI | EC | FR0000120578 | Long | Modellwert (Stufe 2) | 5.745.033 $ | 3,58 | 61.394 | |
| VERTEX PHARMACEUTICALS INCORPORATED | VERTEX PHARMACEUTICALS INC | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 5.703.386 $ | 3,55 | 13.345 | |
| INCYTE CORPORATION | INCYTE CORPORATION | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 5.648.654 $ | 3,52 | 59.291 | |
| GENMAB A/S | GENMAB A S | EC | DK0010272202 | Long | Modellwert (Stufe 2) | 5.078.942 $ | 3,16 | 19.182 | |
| IDEAYA Biosciences Inc | IDEAYA BIOSCIENCES INC | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 4.348.529 $ | 2,71 | 149.434 | |
| Immunitybio Inc | IMMUNITYBIO INC | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 4.188.574 $ | 2,61 | 589.940 | |
| CARIS LIFE SCIENCES, INC. | CARIS LIFE SCIENCES INC | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 3.907.749 $ | 2,44 | 205.671 | |
| ARCUS BIOSCIENCES, INC. | ARCUS BIOSCIENCES INC | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 3.406.775 $ | 2,12 | 133.599 | |
| ONO PHARMACEUTICAL CO., LTD. | ONO PHARMACEUTICAL CO LTD | EC | JP3197600004 | Long | Modellwert (Stufe 2) | 2.992.049 $ | 1,86 | 202.300 | |
| CRISPR Therapeutics AG | CRISPR THERAPEUTICS AG | EC | H17182108 | Long | Börsenkurs (Stufe 1) | 2.896.286 $ | 1,80 | 55.336 | |
| NOVAVAX, INC. | NOVAVAX INC | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 2.096.258 $ | 1,31 | 264.512 | |
| Iovance Biotherapeutics Inc | IOVANCE BIOTHERAPEUTICS INC | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 1.995.450 $ | 1,24 | 593.884 | |
| GenFleet Therapeutics (Shanghai) Inc | GENFLEET THERAPEUTICS SHANGHAI INC | EC | Y2S2YD109 | Long | Modellwert (Stufe 2) | 1.922.243 $ | 1,20 | 345.600 | |
| Nuvation Bio Inc | NUVATION BIO INC | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 1.898.557 $ | 1,18 | 426.642 | |
| Vir Biotechnology Inc | VIR BIOTECHNOLOGY INC | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 1.711.748 $ | 1,07 | 167.572 | |
| ABCELLERA BIOLOGICS INC. | ABCELLERA BIOLOGICS INC | EC | 00288U106 | Long | Börsenkurs (Stufe 1) | 1.706.849 $ | 1,06 | 411.289 | |
| Corvus Pharmaceuticals Inc | CORVUS PHARMACEUTICALS INC | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 1.551.932 $ | 0,97 | 102.168 | |
| Janux Therapeutics Inc | JANUX THERAPEUTICS INC | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 1.378.701 $ | 0,86 | 95.943 | |
| Kura Oncology Inc | KURA ONCOLOGY INC | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 1.328.650 $ | 0,83 | 150.470 | |
| Sunshine Lake Pharma Co Ltd | SUNSHINE LAKE PHARMA CO LTD | EC | Y8243F109 | Long | Börsenkurs (Stufe 1) | 1.001.160 $ | 0,62 | 190.700 | |
| CytomX Therapeutics Inc | CYTOMX THERAPEUTICS INC | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 962.325 $ | 0,60 | 228.039 | |
| Ocugen Inc | OCUGEN INC | EC | 67577C105 | Long | Börsenkurs (Stufe 1) | 949.234 $ | 0,59 | 548.690 | |
| RIGEL PHARMACEUTICALS, INC. | RIGEL PHARMACEUTICALS INC | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 910.726 $ | 0,57 | 31.513 | |
| AbClon Inc. | ABCLON INC | EC | Y0R0KQ104 | Long | Modellwert (Stufe 2) | 903.674 $ | 0,56 | 27.030 | |
| INTELLIA THERAPEUTICS, INC. | INTELLIA THERAPEUTICS INC | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 897.674 $ | 0,56 | 66.593 | |
| Shanghai Henlius Biotech Inc | SHANGHAI HENLIUS BIOTECH INC | EC | CNE100003N76 | Long | Modellwert (Stufe 2) | 805.577 $ | 0,50 | 83.900 | |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | PACIFIC BIOSCIENCES OF CALIFORNIA INC | EC | 69404D108 | Long | Börsenkurs (Stufe 1) | 768.008 $ | 0,48 | 483.024 | |
| Design Therapeutics Inc | DESIGN THERAPEUTICS INC | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 758.350 $ | 0,47 | 55.761 | |
| VALNEVA SE | VALNEVA SE | EC | FR0004056851 | Long | Modellwert (Stufe 2) | 705.395 $ | 0,44 | 258.253 | |
| Ginkgo Bioworks Holdings Inc | GINKGO BIOWORKS HOLDINGS INC | EC | 37611X209 | Long | Börsenkurs (Stufe 1) | 636.979 $ | 0,40 | 75.293 | |
| VERASTEM, INC. | VERASTEM INC | EC | 92337C203 | Long | Börsenkurs (Stufe 1) | 634.867 $ | 0,40 | 116.276 | |
| Alvotech SA | ALVOTECH SA | EC | L01800108 | Long | Börsenkurs (Stufe 1) | 629.186 $ | 0,39 | 188.379 | |
| Personalis Inc | PERSONALIS INC | EC | 71535D106 | Long | Börsenkurs (Stufe 1) | 522.578 $ | 0,33 | 94.670 | |
| Xencor Inc | XENCOR INC | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 484.883 $ | 0,30 | 40.644 | |
| Guangzhou Innogen Pharmaceutical Group Co Ltd | GUANGZHOU INNOGEN PHARMACEUTICAL GROUP CO LTD | EC | Y293B9102 | Long | Börsenkurs (Stufe 1) | 214.848 $ | 0,13 | 120.200 | |
| Prime Medicine Inc | PRIME MEDICINE INC | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 201.519 $ | 0,13 | 56.846 | |
| ARCELLX INC CVR | ARCELLX INC CVR | EC | 039CVR014 | Long | Modellwert (Stufe 2) | 5.114 $ | 0,00 | 73.059 | |
| OMNIAB INC | OMNIAB INC | EC | 68218J301 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 38.996 | |
| 152.613.543 $ | 95,10 | 8.101.705 |